協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/07 | 3,090 | 3,110 | 3,045 | 3,065 | -25 | -0.8% | 919,500 |
2022/01/06 | 3,175 | 3,185 | 3,090 | 3,090 | -105 | -3.3% | 819,900 |
2022/01/05 | 3,185 | 3,205 | 3,150 | 3,195 | +5 | +0.2% | 497,300 |
2022/01/04 | 3,200 | 3,200 | 3,155 | 3,190 | +55 | +1.8% | 439,200 |
2021/12/30 | 3,145 | 3,175 | 3,125 | 3,135 | -25 | -0.8% | 458,700 |
2021/12/29 | 3,165 | 3,200 | 3,135 | 3,160 | -55 | -1.7% | 420,800 |
2021/12/28 | 3,200 | 3,225 | 3,190 | 3,215 | +30 | +0.9% | 457,900 |
2021/12/27 | 3,200 | 3,205 | 3,170 | 3,185 | -20 | -0.6% | 309,600 |
2021/12/24 | 3,225 | 3,235 | 3,195 | 3,205 | -15 | -0.5% | 245,000 |
2021/12/23 | 3,210 | 3,230 | 3,185 | 3,220 | +20 | +0.6% | 318,500 |
2021/12/22 | 3,215 | 3,220 | 3,180 | 3,200 | -10 | -0.3% | 374,900 |
2021/12/21 | 3,170 | 3,230 | 3,170 | 3,210 | +50 | +1.6% | 484,900 |
2021/12/20 | 3,150 | 3,200 | 3,145 | 3,160 | -45 | -1.4% | 459,900 |
2021/12/17 | 3,250 | 3,270 | 3,185 | 3,205 | -85 | -2.6% | 930,300 |
2021/12/16 | 3,340 | 3,340 | 3,235 | 3,290 | +90 | +2.8% | 594,700 |
2021/12/15 | 3,190 | 3,240 | 3,180 | 3,200 | -20 | -0.6% | 585,100 |
2021/12/14 | 3,205 | 3,265 | 3,190 | 3,220 | ±0 | ±0% | 717,800 |
2021/12/13 | 3,250 | 3,260 | 3,220 | 3,220 | +15 | +0.5% | 490,000 |
2021/12/10 | 3,225 | 3,270 | 3,190 | 3,205 | -45 | -1.4% | 916,300 |
2021/12/09 | 3,305 | 3,330 | 3,230 | 3,250 | -35 | -1.1% | 812,900 |
2021/12/08 | 3,270 | 3,295 | 3,250 | 3,285 | +25 | +0.8% | 786,900 |
2021/12/07 | 3,250 | 3,275 | 3,155 | 3,260 | ±0 | ±0% | 1,416,300 |
2021/12/06 | 3,275 | 3,295 | 3,250 | 3,260 | -20 | -0.6% | 577,800 |
2021/12/03 | 3,265 | 3,295 | 3,225 | 3,280 | +15 | +0.5% | 635,100 |
2021/12/02 | 3,185 | 3,295 | 3,180 | 3,265 | +30 | +0.9% | 1,130,600 |
2021/12/01 | 3,170 | 3,255 | 3,135 | 3,235 | +65 | +2.1% | 1,164,600 |
2021/11/30 | 3,270 | 3,305 | 3,160 | 3,170 | -85 | -2.6% | 1,701,100 |
2021/11/29 | 3,285 | 3,305 | 3,240 | 3,255 | -85 | -2.5% | 850,200 |
2021/11/26 | 3,395 | 3,410 | 3,320 | 3,340 | -85 | -2.5% | 951,000 |
2021/11/25 | 3,375 | 3,435 | 3,340 | 3,425 | +50 | +1.5% | 683,400 |
2021/11/24 | 3,400 | 3,415 | 3,340 | 3,375 | ±0 | ±0% | 843,800 |
2021/11/22 | 3,275 | 3,380 | 3,215 | 3,375 | +55 | +1.7% | 1,220,600 |
2021/11/19 | 3,370 | 3,370 | 3,295 | 3,320 | -75 | -2.2% | 1,312,100 |
2021/11/18 | 3,445 | 3,450 | 3,380 | 3,395 | -120 | -3.4% | 1,110,300 |
2021/11/17 | 3,605 | 3,610 | 3,485 | 3,515 | -115 | -3.2% | 921,300 |
2021/11/16 | 3,665 | 3,690 | 3,565 | 3,630 | -75 | -2% | 788,500 |
2021/11/15 | 3,675 | 3,720 | 3,665 | 3,705 | +35 | +1% | 485,300 |
2021/11/12 | 3,690 | 3,725 | 3,655 | 3,670 | -5 | -0.1% | 694,300 |
2021/11/11 | 3,680 | 3,725 | 3,660 | 3,675 | +5 | +0.1% | 504,000 |
2021/11/10 | 3,635 | 3,705 | 3,635 | 3,670 | -30 | -0.8% | 542,800 |
2021/11/09 | 3,760 | 3,785 | 3,695 | 3,700 | -90 | -2.4% | 677,400 |
2021/11/08 | 3,780 | 3,825 | 3,760 | 3,790 | +50 | +1.3% | 622,000 |
2021/11/05 | 3,700 | 3,750 | 3,665 | 3,740 | +40 | +1.1% | 697,400 |
2021/11/04 | 3,785 | 3,785 | 3,625 | 3,700 | +120 | +3.4% | 1,116,400 |
2021/11/02 | 3,615 | 3,620 | 3,455 | 3,580 | -245 | -6.4% | 2,521,100 |
2021/11/01 | 3,795 | 3,835 | 3,760 | 3,825 | +85 | +2.3% | 758,700 |
2021/10/29 | 3,730 | 3,740 | 3,670 | 3,740 | +5 | +0.1% | 584,700 |
2021/10/28 | 3,745 | 3,770 | 3,710 | 3,735 | -40 | -1.1% | 616,400 |
2021/10/27 | 3,730 | 3,780 | 3,720 | 3,775 | +40 | +1.1% | 443,200 |
2021/10/26 | 3,700 | 3,750 | 3,690 | 3,735 | +80 | +2.2% | 713,000 |
701~
750
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム